Stocks Health care CPMD
OTC · Health careCannapharmarx, Inc. (CPMD)
Cannapharmarx, Inc. brought in $1.7M of revenue over the twelve months to June 30, 2026. It posted a net loss of $11.3M. In fiscal 2025 capital spending exceeded operating cash flow by $794.6K. At June 30, 2026 it held $555 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 18, 2026.
Watch CPMD in 60 secondsWhat Cannapharmarx, Inc. does
Cannapharmarx, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker CPMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.4M | -$11.1M | -$0.02 | -$794.6K |
| 2024 | $820.1K | -$9.9M | -$0.02 | -$1.7M |
| 2024 | $0 | $3.7M | $0.01 | -$2.4M |
| 2022 | $0 | -$8.5M | $0.04 | n/a |
| 2021 | $0 | -$8.8M | $0.12 | n/a |
| 2020 | $0 | -$19.9M | -$0.49 | n/a |
Full financial statements: income, balance sheet and cash flow
Where CPMD ranks in Health care
Latest SEC filings
What Cannapharmarx, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 18, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 19% to $276.2K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- August 17, 2026Late quarterly report notice NT 10-Q
- May 20, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 87% to $627.5K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- May 18, 2026Late quarterly report notice NT 10-Q
- March 31, 2026Annual report 10-K · period to December 31, 2025Revenue rose 66% to $1.4M versus the prior year; diluted EPS -$0.02 versus -$0.02.
- January 13, 2026
- December 18, 2025Other event 8-K
- November 14, 2025Quarterly report 10-Q · period to September 30, 2025Revenue rose 110% to $656.6K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- October 10, 2025Other event 8-K
- August 14, 2025
Questions about CPMD
What does Cannapharmarx, Inc. do?
Cannapharmarx, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker CPMD.
Is Cannapharmarx, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $11.3M on revenue of $1.7M.
How much revenue does Cannapharmarx, Inc. make?
Over the twelve months to June 30, 2026 Cannapharmarx, Inc. reported revenue of $1.7M.
When did Cannapharmarx, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 18, 2026. It covers the period to June 30, 2026.
Similar companies
Compare CPMD with
Follow CPMD
Get an email when Cannapharmarx, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CPMD: get an email when it filesWhere the numbers come from
Financial figures are the values Cannapharmarx, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.